E* Chi'mes Round Table Discussion with Dr. Robert Gan at L’Kaisei, Joined by Neurologists, Neurosurgeons, Rehabilitation Medicine Specialists, Internal Medicine Consultants, and Residents.
- Echimes Pharmaceutical
- Aug 6
- 1 min read
E* Chi'mes recently conducted a Round Table Discussion (RTD) led by the esteemed Dr. Robert Gan at L’Kaisei, gathering a distinguished panel of medical professionals, including Neurologists, Neurosurgeons, Rehabilitation Medicine Specialists, Internal Medicine (IM) Consultants, as well as General Surgery (GS) and IM Residents.
The discussion focused on the latest clinical updates and best practices in the management of stroke recovery and neuropathic pain, highlighting the role of NeuroAiD II (MLC 901) and Tripgard (Amitriptyline) in patient care. E* Chi'mes emphasized its continued support for multidisciplinary collaboration, aiming to bridge innovations in therapeutics with real-world clinical applications.
We extend our heartfelt gratitude to all the specialists and residents who actively engaged in this insightful exchange of knowledge. E* Chi'mes remains steadfast in its mission to support continuous medical education and enhance patient outcomes through scientific dialogue and partnerships within the healthcare community.


Comments